Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst

OrganiGram Holdings Inc. OGI recently reported that its net revenue in the 2022 fiscal year increased 84% to CS$145.8 million ($107.9 million) from CA$79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.

CEO Beena Goldenberg attributed the revenue growth to the company’s “innovative product launches, comprehensive retail distribution, sales execution, and operational excellence.”

In his recent note, Cantor Fitzgerald’s analyst Pablo Zuanic said that the company is sustainably gaining a share within the cannabis market.

“In the challenging context of the Canadian market, we think OGI remains one of the best operators,” he said.

The Analyst

Zuanic retained an “Overweight” rating on the company’s stock while keeping the price target of CA$2.90.

The Thesis

The analyst said that out of 19% sequential sales in the fourth quarter, which the company reported on Monday, 70% accounted for exports, even though adjusted gross margins dropped 1.4pt to 22.8%.

Now, the company’s management expects additional sales growth in the next fiscal year.

“We believe it [company] will gain market share on the back of expanded capacity (it was capacity constrained in parts of FY22) and SKU innovation,” Zuanic said, “For the Nov qtr, it guides for gross margin expansion (yields, efficiencies, and operating leverage post the expansion in the Moncton facility).”

Price Action

OrganiGram’s shares traded 2.00% higher at $1.02 per share at the time of writing on Wednesday morning.

Related News

Photo: Courtesy of Markus Winkler on Unsplash

OGI Logo
OGIOrganigram Global Inc
$1.337.26%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
18.39
Growth
-
Quality
-
Value
79.25
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...